哮喘代谢内型揭示肺功能差异:两个TOPMed队列的发现与验证
在GACRS队列中利用非靶向代谢组学、相似性网络融合和谱聚类识别出5种哮喘代谢内型,这些内型在支气管舒张前后FEV1/FVC上存在显著差异,并在CAMP队列中重复验证;胆固醇酯、甘油三酯和脂肪酸是代谢内型归属的重要驱动因素。
要点
- 代谢组学可识别并验证具有临床意义的哮喘内型。
- 5种代谢内型在支气管舒张前后FEV1/FVC上差异显著。
- 胆固醇酯、甘油三酯和脂肪酸是内型归属的主要驱动因素。
核心结论
- 基于代谢组学数据可推导并验证具有临床意义的哮喘内型。
- 探究这些代谢内型的驱动因素有助于理解其病理生理机制。
研究设计与样本
- 在GACRS中采用非靶向代谢组学、相似性网络融合和谱聚类识别哮喘代谢内型。
- 在CAMP中重复验证代谢内型并确定临床差异。
- 通过荟萃分析GACRS和CAMP结果探究代谢内型归属的代谢驱动因素。
主要发现
- GACRS中识别出5种代谢内型,其在支气管舒张前FEV1/FVC上差异显著(p-ANOVA = 8.3 × 10-5)。
- 5种代谢内型在支气管舒张后FEV1/FVC上差异显著(p-ANOVA = 1.8 × 10-5)。
- 上述差异在CAMP重复验证的代谢内型中得到验证。
- 胆固醇酯、甘油三酯和脂肪酸是代谢内型归属的最重要驱动因素之一。
- 研究提示肺表面活性物质稳态失调可能与哮喘严重程度相关。
临床怎么用
- 代谢组学数据可用于推导和验证具有临床意义的哮喘内型。
- 识别代谢内型有助于理解哮喘异质性及肺功能差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Current guidelines do not sufficiently capture the heterogeneous nature of asthma; a more detailed molecular classification is needed. Metabolomics represents a novel and compelling approach to derive asthma endotypes (i.e., subtypes defined by functional and/or pathobiological mechanisms). Objectives: To validate metabolomic-driven endotypes of asthma and explore their underlying biology. Methods: In the Genetics of Asthma in Costa Rica Study (GACRS), untargeted metabolomic profiling, similarity network fusion, and spectral clustering was used to identify metabo-endotypes of asthma, and differences in asthma-relevant phenotypes across these metabo-endotypes were explored. The metabo-endotypes were recapitulated in the Childhood Asthma Management Program (CAMP), and clinical differences were determined. Metabolomic drivers of metabo-endotype membership were investigated by meta-analyzing findings from GACRS and CAMP. Measurements and Main Results: Five metabo-endotypes were identified in GACRS with significant differences in asthma-relevant phenotypes, including prebronchodilator (p-ANOVA = 8.3 × 10-5) and postbronchodilator (p-ANOVA = 1.8 × 10-5) FEV1/FVC. These differences were validated in the recapitulated metabo-endotypes in CAMP. Cholesterol esters, trigylcerides, and fatty acids were among the most important drivers of metabo-endotype membership. The findings suggest dysregulation of pulmonary surfactant homeostasis may play a role in asthma severity. Conclusions: Clinically meaningful endotypes may be derived and validated using metabolomic data. Interrogating the drivers of these metabo-endotypes has the potential to help understand their pathophysiology.
引用
- Kelly RS, Mendez KM, Huang M, et al. Metabo-Endotypes of Asthma Reveal Differences in Lung Function: Discovery and Validation in Two TOPMed Cohorts. Am J Respir Crit Care Med. 2022. PMID: 34767496. doi:10.1164/rccm.202105-1268OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。